ADC THERAPEUTICS SA (ADCT)
CH0499880968 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ADCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 700% above the current price.
ADCT was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ADCT.
In the previous month the buy percentage consensus was at a similar level.
ADCT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-09 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-11-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-10 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-08-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-10 | RBC Capital | Maintains | Outperform |
| 2023-04-24 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-02-13 | RBC Capital | Maintains | Outperform |
| 2023-01-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-04 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-14 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-09 | RBC Capital | Maintains | Outperform |
| 2022-11-09 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-09-21 | JP Morgan | Initiate | Overweight |
| 2022-09-19 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-09 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-08-22 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-10 | RBC Capital | Maintains | Outperform |
| 2022-07-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-10 | RBC Capital | Maintains | Outperform |
| 2022-05-10 | Morgan Stanley | Maintains | Overweight |
| 2022-04-12 | Morgan Stanley | Maintains | Overweight |
| 2022-03-04 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-01 | Morgan Stanley | Maintains | Overweight |
| 2021-11-09 | Wolfe Research | Initiate | Outperform |